An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia

Dermatology

Volumn 209, Issue 2, 2004, Pages 117-125

  Arca, Ercan ^a   Açikgöz, Gürol ^a   Taştan, Halis Bülent ^a   Köse, Osman ^a   Kurumlu, Zafer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Androgenetic alopecia; Finasteride; Minoxidil

Indexed keywords

FINASTERIDE; MINOXIDIL; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HAIR DISEASE; HAIR GROWTH; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOPECIA; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FINASTERIDE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINOXIDIL; PATIENT SATISFACTION; PROBABILITY; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 4444233291     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079595     Document Type: Article

References (32)

1. Vecchio F, Guarrera M, Rebora A: Perception of baldness and hair density. Dermatology 2002;204:33-36.
2. Hoffmann R: Male androgenetic alopecia. Clin Exp Dermatol 2002;27:373-382.
3. Sawaya ME: Androgenetic alopecia: Overview. J Cutan Med Surg 1999;3(suppl 3):S14-S20.
4. Bouhanna P: Multifactorial classification of male and female androgenetic alopecia. Dermatol Surg 2000;26:555-561.
5. Wiseman MC, Shapiro J: Therapeutic approach to androgenetic alopecia. J Cutan Med Surg 1999;3(suppl 3):S21-S29.
6. McClellan KJ, Markham A: Finasteride: A review of its use in male pattern hair loss. Drugs 1999;57:111-126.
7. Kaufman KD, Olsen EA, Whiting D, Savin R, et al: Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-589.
8. Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, et al: Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999;40:930-937.
9. Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, et al: Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 1999;41:555-563.
10. Brenner S, Matz H: Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride. Int J Dermatol 1999;38:928-930.
11. Whiting DA: Advances in the treatment of male androgenetic alopecia: A brief review of finasteride studies. Eur J Dermatol 2001;11:332-334.
12. Wolff H, Kunte C: Current management of androgenetic alopecia in men. Eur J Dermatol 1999;9:606-609.
13. Hoffmann R, Happle R: Current understanding of androgenetic alopecia. II. Clinical aspects and treatment. Eur J Dermatol 2000;10:410-417.
14. Messenger AG: Medical management of male pattern hair loss. Int J Dermatol 2000;39:585-586.
15. Price VH, Menefee E, Strauss PC: Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5 and 2 % topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41:717-721.
16. Olsen EA, Dunlap FE, Funicella T, Koperski JA, et al: A randomized clinical trial of 5 % topical minoxidil versus 2 % topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47:377-385.
17. Walsh DS, Dunn CL, James WD: Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride. Arch Dermatol 1995;131:1373-1375.
18. Sinclair RD, Dawber RPR: Androgenetic alopecia in men and women. Clin Dermatol 2001;19:167-178.
19. Whiting DA, Olsen EA, Savin R, Halper L, et al: Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol 2003;13:150-160.
20. Kaufman KD: The Finasteride Male Pattern Hair Loss Study group: Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.
21. Shapiro J, Kaufman KD: Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). JID Symp Proc 2003;8:20-23.
22. Diani AR, Muhholland MJ, Shull KL, Kubice MF, et al: Hair growth effects of oral administration of finasteride, a steroid 5α-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. J Clin Endocrinol Metab 1992;74:345-350.
23. Khandpour S, Suman M, Reddy BS: Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002;29:489-498.
24. Saraswat A, Kumar B: Minoxidil vs finasteride in the treatment of men with androgenetic alopecia. Arch Dermatol 2003;139:1219-1221.
25. Scheman AJ, West DP, Hordinsky MK, Osburn AH, West LE: Alternative formulation for patients with contact reactions to topical 2 and 5 % minoxidil vehicle ingredients. Contact Dermatitis 2000;42:241.
26. Friedman ES, Friedman PM, Cohen DE, Washenik K: Allergic contact dermatitis to topical minoxidil solution: Etiology and treatment. J Am Acad Dermatol 2002;46:309-312.
27. Trattner A, David M: Pigmented contact dermatitis from topical minoxidil 5 %. Contact Dermatitis 2002;46:246.
28. Dawber RPR, Rundegren J: Hypertrichosis in females applying minoxidil topical solution and in normal controls. J Eur Acad Dermatol Venereol 2003;17:271-275.
29. Tosti A, Piraccini BM, Soli M: Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. J Eur Acad Dermatol Venereol 2001;15:418-421.
30. Price VH, Roberts JL, Hordinsky M, Olsen EA, et al: Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000;43:768-776.
31. Thai KE, Sinclair RD: Finasteride for female androgenetic alopecia. Br J Dermatol 2002;147:812-813.
32. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, et al: The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999;41:550-554